Damnacanthal, a noni component, exhibits antitumorigenic activity in human colorectal cancer cells

Journal of Nutritional Biochemistry

Volumn 23, Issue 8, 2012, Pages 915-923

  Nualsanit, Thararat ^a,b   Rojanapanthu, Pleumchitt ^b   Gritsanapan, Wandee ^b   Lee, Seong Ho ^a   Lawson, Darunee ^c   Baek, Seung Joon ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

^b MAHIDOL UNIVERSITY   (Thailand)

^c UNIVERSITY OF TENNESSEE   (United States)

Author keywords

C EBP ; Colorectal cancer; Damnacanthal; GDF15; NAG 1; Noni

Indexed keywords

CASPASE; CCAAT BINDING FACTOR; DAMNACANTHAL; MORINDA CITRIFOLIA EXTRACT; NONSTEROIDAL ANTIINFLAMMATORY ACTIVATED GENE 1; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CARCINOGENESIS; CELL CYCLE ARREST; CELL GROWTH; COLORECTAL CANCER; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; MORINDA CITRIFOLIA; PLANT ROOT; PROTEIN TARGETING; TRANSCRIPTION REGULATION;

ANTHRAQUINONES; ANTICARCINOGENIC AGENTS; CCAAT-ENHANCER-BINDING PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; COLORECTAL NEOPLASMS; GROWTH DIFFERENTIATION FACTOR 15; HCT116 CELLS; HUMANS; MORINDA;

MORINDA CITRIFOLIA;

EID: 84863992249     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2011.04.017     Document Type: Article

References (41)

1. Jemal A., Siegel R., Xu J., Ward E. Cancer statistics. CA Cancer J Clin 2010.
2. Rajamanickam S., Agarwal R. Natural products and colon cancer: current status and future prospects. Drug Dev Res 2008, 69:460-471.
3. Wang M., et al. Morinda citrifolia (noni): a literature review and recent advances in Noni research. Acta Pharmacol Sin 2002, 23:1127-1141.
4. Lemmens R., Bunyapraphatsara N. Plant resources of South-East Asia 2003, Backhuys Publishers, Leiden.
5. Hornick C., Myers A., Sadowska-Krowicka H., Anthony C., Woltering E. Inhibition of angiogenic initiation and disruption of newly established human vascular networks by juice from Morinda citrifolia (noni). Angiogenesis 2003, 6:143-149.
6. Wang M.Y., Su C. Cancer preventive effect of Morinda citrifolia (noni). Ann N Y Acad Sci 2001, 952:161-168.
7. Palu A.K., Kim A.H., West B.J., Deng S., Jensen J., White L. The effects of Morinda citrifolia L. (noni) on the immune system: its molecular mechanisms of action. J Ethnopharmacol 2008, 115:502-506.
8. Li J., Stickel S.L., Bouton-Verville H., Burgin K.E., Yu X., Wong D.K., et al. Fermented noni exudate (fNE): a mediator between immune system and anti-tumor activity. Oncol Rep 2008, 20:1505-1509.
9. Furusawa E., Hirazumi A., Story S., Jensen J. Antitumour potential of a polysaccharide-rich substance from the fruit juice of Morinda citrifolia (noni) on sarcoma 180 ascites tumour in mice. Phytother Res 2003, 17:1158-1164.
10. Hirazumi A., Furusawa E. An immunomodulatory polysaccharide-rich substance from the fruit juice of Morinda citrifolia (noni) with antitumour activity. Phytother Res 1999, 13:380-387.
11. Faltynek C.R.S.J., Mauvais P., Miller D., Wang S., et al. Damnacanthal is a highly potent, selective inhibitor of p56lck tyrosine kinase activity. Biochemistry 1995, 34:12404-12410.
12. Kanokmedhakul K., Kanokmedhakul S., Phatchana R. Biological activity of anthraquinones and triterpenoids from Prismatomeris fragrans. J Ethnopharmacol 2005, 100:284-288.
13. Baek S.J., Kim K.S., Nixon J.B., Wilson L.C., Eling T.E. Cyclooxygenase inhibitors regulate the expression of a TGF-beta superfamily member that has proapoptotic and antitumorigenic activities. Mol Pharmacol 2001, 59:901-908.
14. Baek S.J., Eling T.E. Changes in gene expression contribute to cancer prevention by COX inhibitors. Prog Lipid Res 2006, 45:1-16.
15. Baek S.J., Okazaki R., Lee S.H., Martinez J., Kim J.S., Yamaguchi K., et al. Nonsteroidal anti-inflammatory drug-activated gene-1 over expression in transgenic mice suppresses intestinal neoplasia. Gastroenterology 2006, 131:1553-1560.
16. Cekanova M., Lee S.H., Donnell R.L., Sukhthankar M., Eling T.E., Fischer S.M., et al. Nonsteroidal anti-inflammatory drug-activated gene-1 expression inhibits urethane-induced pulmonary tumorigenesis in transgenic mice. Cancer Prev Res (Phila) 2009, 2:450-458.
17. Baek S.J., Kim J.S., Moore S.M., Lee S.H., Martinez J., Eling T.E. Cyclooxygenase inhibitors induce the expression of the tumor suppressor gene EGR-1, which results in the up-regulation of NAG-1, an antitumorigenic protein. Mol Pharmacol 2005, 67:356-364.
18. Baek S.J., Wilson L.C., Eling T.E. Resveratrol enhances the expression of non-steroidal anti-inflammatory drug-activated gene (NAG-1) by increasing the expression of p53. Carcinogenesis 2002, 23:425-434.
19. Lee S.H., Krisanapun C., Baek S.J. NSAID-activated gene-1 as a molecular target for capsaicin-induced apoptosis through a novel molecular mechanism involving GSK3beta, C/EBPbeta and ATF3. Carcinogenesis 2010, 31:719-728.
20. Lee S.H., Yamaguchi K., Kim J.S., Eling T.E., Safe S., Park Y., et al. Conjugated linoleic acid stimulates an anti-tumorigenic protein NAG-1 in an isomer specific manner. Carcinogenesis 2006, 27:972-981.
21. Hiramatsu T., Imoto M., Koyano T., Umezawa K. Induction of normal phenotypes in ras-transformed cells by damnacanthal from Morinda citrifolia. Cancer Lett 1993, 73:161-166.
22. Baek S.J., Horowitz J.M., Eling T.E. Molecular cloning and characterization of human nonsteroidal anti-inflammatory drug-activated gene promoter. Basal transcription is mediated by Sp1 and Sp3. J Biol Chem 2001, 276:33384-33392.
23. Lee S.H., Bahn J.H., Whitlock N.C., Baek S.J. Activating transcription factor 2 (ATF2) controls tolfenamic acid-induced ATF3 expression via MAP kinase pathways. Oncogene 2010, 29:5182-5192.
24. Auyeung K.K., Ko J.K. Coptis chinensis inhibits hepatocellular carcinoma cell growth through nonsteroidal anti-inflammatory drug-activated gene activation. Int J Mol Med 2009, 24:571-577.
25. Jutooru I., Chadalapaka G., Chintharlapalli S., Papineni S., Safe S. Induction of apoptosis and nonsteroidal anti-inflammatory drug-activated gene 1 in pancreatic cancer cells by a glycyrrhetinic acid derivative. Mol Carcinog 2009, 48:692-702.
26. Wu Z., Xie Y., Bucher N.L., Farmer S.R. Conditional ectopic expression of C/EBP beta in NIH-3T3 cells induces PPAR gamma and stimulates adipogenesis. Genes Dev 1995, 9:2350-2363.
27. Park B.H., Qiang L., Farmer S.R. Phosphorylation of C/EBPbeta at a consensus extracellular signal-regulated kinase/glycogen synthase kinase 3 site is required for the induction of adiponectin gene expression during the differentiation of mouse fibroblasts into adipocytes. Mol Cell Biol 2004, 24:8671-8680.
28. Potter J.D., Slattery M.L., Bostick R.M., Gapstur S.M. Colon cancer: a review of the epidemiology. Epidemiol Rev 1993, 15:499-545.
29. Wenzel U., Kuntz S., Brendel M.D., Daniel H. Dietary flavone is a potent apoptosis inducer in human colon carcinoma cells. Cancer Res 2000, 60:3823-3831.
30. Yamaguchi K., Lee S.H., Eling T.E., Baek S.J.A. novel peroxisome proliferator-activated receptor gamma ligand, MCC-555, induces apoptosis via posttranscriptional regulation of NAG-1 in colorectal cancer cells. Mol Cancer Ther 2006, 5:1352-1361.
31. Hiwasa T., Arase Y., Chen Z., Kita K., Umezawa K., Ito H., et al. Stimulation of ultraviolet-induced apoptosis of human fibroblast UVr-1 cells by tyrosine kinase inhibitors. FEBS Lett 1999, 444:173-176.
32. Salmenpera P., Hamalainen S., Hukkanen M., Kankuri E. Interferon-gamma induces C/EBP beta expression and activity through MEK/ERK and p38 in T84 colon epithelial cells. Am J Physiol Cell Physiol 2003, 284:C1133-1139.
33. Martinez J.M., Sali T., Okazaki R., Anna C., Hollingshead M., Hose C., et al. Drug-induced expression of nonsteroidal anti-inflammatory drug-activated gene/macrophage inhibitory cytokine-1/prostate-derived factor, a putative tumor suppressor, inhibits tumor growth. J Pharmacol Exp Ther 2006, 318:899-906.
34. Chen Y.L., Lin P.C., Chen S.P., Lin C.C., Tsai N.M., Cheng Y.L., et al. Activation of nonsteroidal anti-inflammatory drug-activated gene-1 via extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase revealed a isochaihulactone-triggered apoptotic pathway in human lung cancer A549 cells. J Pharmacol Exp Ther 2007, 323:746-756.
35. Blobel G.A. CREB-binding protein and p300: molecular integrators of hematopoietic transcription. Blood 2000, 95:745-755.
36. Foti D., Iuliano R., Chiefari E., Brunetti A.A. nucleoprotein complex containing Sp1, C/EBP beta, and HMGI-Y controls human insulin receptor gene transcription. Mol Cell Biol 2003, 23:2720-2732.
37. Weber M., Sydlik C., Quirling M., Nothdurfter C., Zwergal A., Heiss P., et al. Transcriptional inhibition of interleukin-8 expression in tumor necrosis factor-tolerant cells: evidence for involvement of C/EBP beta. J Biol Chem 2003, 278:23586-23593.
38. Boruk M., Savory J.G., Hache R.J. AF-2-dependent potentiation of CCAAT enhancer binding protein beta-mediated transcriptional activation by glucocorticoid receptor. Mol Endocrinol 1998, 12:1749-1763.
39. van Hattem W.A., Brosens L.A., Marks S.Y., Milne A.N., van Eeden S., Iacobuzio-Donahue C.A., et al. Increased cyclooxygenase-2 expression in juvenile polyposis syndrome. Clin Gastroenterol Hepatol 2009, 7:93-97.
40. Eisinger A.L., Nadauld L.D., Shelton D.N., Peterson P.W., Phelps R.A., Chidester S., et al. The adenomatous polyposis coli tumor suppressor gene regulates expression of cyclooxygenase-2 by a mechanism that involves retinoic acid. J Biol Chem 2006, 281:20474-20482.
41. Sun L., Fu B.B., Liu D.G. Systemic delivery of full-length C/EBP beta/liposome complex suppresses growth of human colon cancer in nude mice. Cell Res 2005, 15:770-776.